Skip Navigation

Cardiovascular Research 1999 42(3):616-626; doi:10.1016/S0008-6363(98)00332-0
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bache, R. J.
Right arrow Articles by Ugurbil, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bache, R. J.
Right arrow Articles by Ugurbil, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy

Robert J. Bache*, Jianyi Zhang, Yo Murakami, Yi Zhang, Yong K. Cho, Helmut Merkle, Guangrong Gong, Arthur H.L. From and Kamil Ugurbil

Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Box 508, UMHC, Minneapolis, MN 55455, USA

* Corresponding author. Tel.: +1-612-625-2454; Fax: +1-612-626-4411. E-mail address: bache001@maroon.tc.umn.edu (R.J. Bache)

Background: High cardiac workloads produced by catecholamine infusion result in loss of myocardial phosphocreatine (PCr) and accumulation of inorganic phosphate (Pi) which are more prominent in hearts with left ventricular hypertrophy (LVH) than in normal hearts. Since ischemia can cause changes in phosphorylated compounds similar to those during catecholamine stimulation, this study tested the hypothesis that the exaggerated depletion of PCr and accumulation of Pi during high workloads in LVH is the result of impaired myocyte oxygenation. Methods and results: 31P- and 1H-NMR spectroscopy were used to determine myocardial high energy phosphate levels and myoglobin desaturation, respectively, in eight normal dogs and nine dogs with LVH produced by ascending aortic banding. The mean LV weight/body weight ratio was approximately twice normal in the LVH group. Infusion of dobutamine (15 and 30 µg/kg/min), and dobutamine+dopamine (each 20 µg/kg/min) caused progressive similar increases in the heart ratexsystolic LV pressure product to a maximum of 57.4±3.3·103 in normal and 63.9±2.7·103 in LVH animals, while myocardial oxygen consumption increased from 0.09±0.01 to 0.24±0.04 in normals and from 0.10±0.02 to 0.25±0.03 ml/min/g in LVH. PCr/ATP ratios during basal conditions were lower in LVH hearts (1.73±0.10, 1.61±0.09 and 1.51±0.09 in subepicardium, midwall and subendocardium, respectively) as compared with normals (2.24±0.09, 2.01±0.08 and 1.89±0.07; each p<0.01 normal vs. LVH). Catecholamine infusions caused dose-related decreases in PCr/ATP and appearance of Pi which was more marked in LVH than in normal hearts. 1H-NMR spectroscopy did not detect deoxymyoglobin in either normal or LVH hearts even during the highest workloads. In contrast, occlusion of the anterior descending coronary artery resulted in a large deoxymyoglobin signal. Conclusions: Increases of cardiac work produced by catecholamine stimulation resulted in greater decreases of PCr and greater increases of Pi in hypertrophied than in normal hearts. These abnormalities were not the result of inadequate intracellular oxygen availability and consequently cannot be ascribed to demand ischemia.

KEYWORDS High energy phosphates; Deoxymyoglobin; Nuclear magnetic resonance; Phosphocreatine; Dog


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Wu, J. Zhang, and D. A. Beard
Experimentally observed phenomena on cardiac energetics in heart failure emerge from simulations of cardiac metabolism
PNAS, April 28, 2009; 106(17): 7143 - 7148.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. Wu, E. Y. Zhang, J. Zhang, R. J. Bache, and D. A. Beard
Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts
J. Physiol., September 1, 2008; 586(17): 4193 - 4208.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. W. Schwenk, J. J.F.P. Luiken, A. Bonen, and J. F.C. Glatz
Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease
Cardiovasc Res, July 15, 2008; 79(2): 249 - 258.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Y. Maslov, V. P. Chacko, M. Stuber, A. L. Moens, D. A. Kass, H. C. Champion, and R. G. Weiss
Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H387 - H391.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. S. Smith, P. A. Bottomley, S. P. Schulman, G. Gerstenblith, and R. G. Weiss
Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium
Circulation, September 12, 2006; 114(11): 1151 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Chung
Oxygen reperfusion is limited in the postischemic hypertrophic myocardium
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2075 - H2084.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. V. Naumova, V. P. Chacko, R. Ouwerkerk, L. Stull, E. Marban, and R. G. Weiss
Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H837 - H843.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. C. Ejike, L. S. L. Arakaki, D. A. Beard, W. A. Ciesielski, E. O. Feigl, and K. A. Schenkman
Myocardial oxygenation and adenosine release in isolated guinea pig hearts during changes in contractility
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2062 - H2067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Fujii, T. Nozawa, A. Igawa, B.-i. Kato, N. Igarashi, M. Nonomura, H. Asanoi, S. Tazawa, M. Inoue, and H. Inoue
Saturated glucose uptake capacity and impaired fatty acid oxidation in hypertensive hearts before development of heart failure
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H760 - H766.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. S. Ingwall and R. G. Weiss
Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function
Circ. Res., July 23, 2004; 95(2): 135 - 145.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. van Bilsen, P. J.H Smeets, A. J Gilde, and G. J van der Vusse
Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
Cardiovasc Res, February 1, 2004; 61(2): 218 - 226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. V. Naumova, R. G. Weiss, and V. P. Chacko
Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1976 - H1979.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Gong, J. Liu, P. Liang, T. Guo, Q. Hu, K. Ochiai, M. Hou, Y. Ye, X. Wu, A. Mansoor, et al.
Oxidative capacity in failing hearts
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H541 - H548.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. P Lydell, A. Chan, R. B Wambolt, N. Sambandam, H. Parsons, G. P Bondy, B. Rodrigues, K. M Popov, R. A Harris, R. W Brownsey, et al.
Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts
Cardiovasc Res, March 1, 2002; 53(4): 841 - 851.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. A. Schenkman
Cardiac performance as a function of intracellular oxygen tension in buffer-perfused hearts
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2463 - H2472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Liu, C. Wang, Y. Murakami, G. Gong, Y. Ishibashi, C. Prody, K. Ochiai, R. J. Bache, C. Godinot, and J. Zhang
Mitochondrial ATPase and high-energy phosphates in failing hearts
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1319 - H1326.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ye, C. Wang, J. Zhang, Y. K. Cho, G. Gong, Y. Murakami, and R. J. Bache
Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H376 - H386.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Marin-Garcia, M. J Goldenthal, and G. W Moe
Mitochondrial pathology in cardiac failure
Cardiovasc Res, January 1, 2001; 49(1): 17 - 26.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Gibbs
Respiratory control in normal and hypertrophic hearts
Cardiovasc Res, June 1, 1999; 42(3): 567 - 570.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.